Naomi Hasegawa

Kodaira, 1878553, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 65 publications

Educational spillover effect within a cluster: Impact of guideline education for schizophrenia and major depressive disorder on psychiatrists' treatment behavior in a real-world multicenter study.

Educational spillover effect within a cluster: Impact of guideline education for schizophrenia and major depressive disorder on psychiatrists' treatment behavior in a real-world multicenter study.

Journal: Asian journal of psychiatry

Published: January 08, 2026

Eight-Year Progression of Clinical Practice Implementation Following Guideline Training in the EGUIDE Project.

Eight-Year Progression of Clinical Practice Implementation Following Guideline Training in the EGUIDE Project.

Journal: Neuropsychopharmacology reports

Published: November 04, 2025

Clinical behavior toward outpatients with major depressive disorder based on guideline education for psychiatrists.

Clinical behavior toward outpatients with major depressive disorder based on guideline education for psychiatrists.

Journal: PCN reports : psychiatry and clinical neurosciences

Published: August 13, 2025

Long-Term Impact of EGUIDE Training on Facility-Wide Guideline Adherence Rate in Schizophrenia and Major Depressive Disorder: A Multicenter Study.

Long-Term Impact of EGUIDE Training on Facility-Wide Guideline Adherence Rate in Schizophrenia and Major Depressive Disorder: A Multicenter Study.

Journal: Neuropsychopharmacology reports

Published: August 12, 2025

Association Between Psychiatrists' Subjective Clinical Behavior Scores and Objective Quality Indicators Based on Discharge Prescriptions: A Nationwide Multicenter Study Based on the EGUIDE Project.

Association Between Psychiatrists' Subjective Clinical Behavior Scores and Objective Quality Indicators Based on Discharge Prescriptions: A Nationwide Multicenter Study Based on the EGUIDE Project.

Journal: Neuropsychopharmacology reports

Published: August 02, 2025

A Data-Driven Psychiatric Disorder Subtype Defined by Significant Enlarged Ventricles and Cognitive Impairment: A Replication Study.

A Data-Driven Psychiatric Disorder Subtype Defined by Significant Enlarged Ventricles and Cognitive Impairment: A Replication Study.

Journal: Neuropsychopharmacology reports

Published: June 04, 2025

Cognitive profile of psychiatric patients with coexisting enlarged ventricles and cognitive impairment: A rare cross-diagnostic phenotype predominantly observed in schizophrenia.

Cognitive profile of psychiatric patients with coexisting enlarged ventricles and cognitive impairment: A rare cross-diagnostic phenotype predominantly observed in schizophrenia.

Journal: Psychiatry and clinical neurosciences

Published: June 03, 2025

Clinical Characteristics of Patients With Enlarged Ventricles and Cognitive Impairment (EVCI): Case Series.

Clinical Characteristics of Patients With Enlarged Ventricles and Cognitive Impairment (EVCI): Case Series.

Journal: Neuropsychopharmacology reports

Published: April 13, 2025

Optimizing multi-site schizophrenia differentiation: MRI harmonization with 20 controls per scanner in a study of 3560 subjects across 15 MRI scanners.

Optimizing multi-site schizophrenia differentiation: MRI harmonization with 20 controls per scanner in a study of 3560 subjects across 15 MRI scanners.

Journal: Progress in neuro-psychopharmacology & biological psychiatry

Published: April 09, 2025

Proposal for a Novel Classification of Patients With Enlarged Ventricles and Cognitive Impairment Based on Data-Driven Analysis of Neuroimaging Results in Patients With Psychiatric Disorders.

Proposal for a Novel Classification of Patients With Enlarged Ventricles and Cognitive Impairment Based on Data-Driven Analysis of Neuroimaging Results in Patients With Psychiatric Disorders.

Journal: Neuropsychopharmacology reports

Published: December 23, 2024

Usefulness of the WAIS-IV Short Form for Measuring Cognitive Function in Patients With Schizophrenia.

Usefulness of the WAIS-IV Short Form for Measuring Cognitive Function in Patients With Schizophrenia.

Journal: Neuropsychopharmacology reports

Published: October 01, 2024

The association between benzodiazepine prescriptions and the risk of laxative use in schizophrenia treatment.

The association between benzodiazepine prescriptions and the risk of laxative use in schizophrenia treatment.

Journal: Neuropsychopharmacology reports

Published: September 14, 2024

Showing 1-12 of 65

Last Updated: 09/26/2026